ESTRADIOL 0.5 MG / PROGESTERONE 100 MG ORAL CAPSULE [BIJUVA]

Side Effects & Adverse Event Reports


View Chart Data

32.1K

Adverse Events

140.9K

Side Effects

2000

Data Starting In

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on ESTRADIOL 0.5 MG / PROGESTERONE 100 MG ORAL CAPSULE [BIJUVA].

Understanding the potential Side Effects and Adverse Events of ESTRADIOL 0.5 MG / PROGESTERONE 100 MG ORAL CAPSULE [BIJUVA] is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how ESTRADIOL 0.5 MG / PROGESTERONE 100 MG ORAL CAPSULE [BIJUVA] may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about ESTRADIOL 0.5 MG / PROGESTERONE 100 MG ORAL CAPSULE [BIJUVA] are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for ESTRADIOL 0.5 MG / PROGESTERONE 100 MG ORAL CAPSULE [BIJUVA]?

    SymPedia shows ESTRADIOL 0.5 MG / PROGESTERONE 100 MG ORAL CAPSULE [BIJUVA] adverse event reports for 32,127.

  • How many side effects have been reported for ESTRADIOL 0.5 MG / PROGESTERONE 100 MG ORAL CAPSULE [BIJUVA]?

    SymPedia shows ESTRADIOL 0.5 MG / PROGESTERONE 100 MG ORAL CAPSULE [BIJUVA] side effect reports for 140,906.

  • What year does the ESTRADIOL 0.5 MG / PROGESTERONE 100 MG ORAL CAPSULE [BIJUVA] reporting data start?

    SymPedia reporting data on this page starts in 2000.

  • What years are included in the yearly chart for ESTRADIOL 0.5 MG / PROGESTERONE 100 MG ORAL CAPSULE [BIJUVA]?

    SymPedia yearly chart data on this page covers 2000 to 2025.